Register | Recover Password

Top Marijuana Shares from the NASDAQ

Top Marijuana Shares from the NASDAQ

Even though the majority of U.S.-based cannabis organizations and lots of foreign American Depository Receipts (ADRs) trade on the countertop (OTC), a marijuana that is few are exchanged from the NASDAQ. Some investors choose shares which can be noted on the NASDAQ with other exchanges for their increased liquidity and tighter spreads set alongside the markets that are over-the-counter. For instance, because the cannabis industry has exploded in present months and years, uplisting from an OTC market to a professional U.S. change has grown to become an advertising achievement for most increasing marijuana businesses. (For associated reading, see “Understanding Medical Cannabis vs. Recreational Cannabis shares”)

An increasing quantity of cannabis organizations are now being listed on reputable U.S. exchanges in the place of being exchanged regarding the OTC market showing the quick development of the cannabis industry.

NASDAQ-listed Marijuana shares

The NASDAQ had been the very first exchange that is electronic is definitely synonymous with technology and biotechnology. The cannabis businesses on the NASDAQ mirror this, and also the majority of them operate within the area that is biotech of industry. Here you will find the NASDAQ-listed marijuana shares, in alphabetical purchase, at the time of October 26, 2019, with a dysfunction of these total returns.

Arena Pharmaceuticals, Inc. (NASDAQ:ARNA)

Arena Pharmaceuticals is just a biotech company active in the manufacturing of medical marijuana medications. Research and development around Arena’s APD371 may be the focus that is primary of firm’s cannabis biotech initiatives.

Atlantic Alliance Partnership Corp. (NASDAQ:AAPC)

Atlantic Alliance Partnership Corp. is just a check this is certainly blank that is in a merger contract with Kalyx developing Inc. Kalyx is a respected investment trust in the regulated cannabis industry in america.

Key Takeaways

  • The cannabis industry, specially the part of marijuana and biotech, is attracting investor attention that is substantial.
  • Cannabis will be utilized in brand new medications for the treatment of pain and chronic that is many inflammatory, and fibrotic conditions.
  • Organizations may also be developing cannabinoid items for autism range problems, schizophrenia, glioma, Tourette problem, epileptic problems, Prader-Willi Syndrome (an inherited condition), and amphetamine addiction.

Cara Therapeutics Inc. (NASDAQ:CARA)

Cara Therapeutics is a clinical-stage biotechnology business focused on developing and commercializing chemical that is new when it comes to indications of pain and pruritus (itching). Although most of the firm’s clinical-stage items target opioid receptors, Cara is conducting research that is preclinical cannabinoids for the treating neuropathic discomfort.

Corbus Pharmaceuticals Holdings Inc. (NASDAQ:CRBP)

Corbus Pharmaceuticals Holdings Inc. is really a cannabis biotech business. The group’s research, development, and production are based around cannabis medications that look for to deal with chronic, inflammatory, fibrotic, along with other conditions.

Cronos Group Inc. (NASDAQ:CRON)

Cronos Group Inc. is really A canadian cannabis business. The team owns and seeks cannabis-related subsidiaries and licensed manufacturers. In December of 2018, Marlboro manufacturer Altria announced intends to spend $1.8 billion in Cronos. The investment has provided Cronos not only with extra money to invest in its continued expansion but additionally with a well-established partner skilled when you look at the marketing of customer brands.

Greenlane Holdings Inc. (NASDAQ:GNLN)

Greenlane Holdings Inc. is a Boca Raton, Florida-based cannabis company. It distributes many different cannabis usage add-ons and vaporization equipment and products to customers that are retail the U.S. and Canada. Furthermore, it runs e-commerce websites for extra product sales.

GW Pharmaceuticals Plc. (NASDAQ:GWPH)

GW Pharmaceuticals is having a profile of cannabinoid medications. These medications consist of Sativex for the treating spasticity linked to multiple sclerosis and cancer tumors discomfort and Epidiolex to treat youth epilepsy. Sativex is commercialized much more compared to a dozen nations away from united states of america and contains gotten approval that is regulatory other nations. Epidiolex received Food And Drug Administration approval as a treatment for Dravet Syndrome and Lennox-Gastaut Syndrome, two kinds of serious, early onset epilepsy without good existing treatment plans. Other indications reveal that GW Pharmaceuticals is developing products that are cannabinoid autism range problems, schizophrenia, and glioma.

Intec Pharma Ltd. (NASDAQ:NTEC)

Intec Pharma is just a clinical-stage biopharmaceutical business that is developing medications according to its proprietary Accordion Pill technology. Intec’s item pipeline includes cannabinoid-based medications for lower pain that is back fibromyalgia.

Marrone Bio Innovations, Inc. (NASDAQ:MBII)

Marrone Bio Innovations, Inc. develops and distributes environmentally responsible bio-based management that is pest plant wellness items. In 2017, Marrone Bio Innovations announced that three MBII active ingredients are now appropriate for usage on cannabis crops within the California cultivation market.

Modern Age Beverages Corp. (NASDAQ:NBEV)

Modern Beverages Corp. is just a maker of beverages based on yerba mate, green tea leaf, kombucha, and similar items. In present months, modern age has expanded its beverage offerings to add CBD infusions too, bringing it in to the orbit of cannabis stocks.

OrganiGram Holdings Inc. (NASDAQ:OGI)

Canadian cannabis producer OrganiGram Holdings Inc. debuted from the NASDAQ in might of 2019, which makes it perhaps one of the most present cannabis organizations to record regarding the popular change. The organization was rapidly expanding its manufacturing capacity that will have the ability to create just as much as 113,000 kilograms of product per 12 months by the end of 2019.

Psychemedics Corporation (NASDAQ:PMD)

Psychemedics Corporation runs into the enforcement sector. The business’s business operations support drug evaluation through hair examples.

Sundial Growers Inc. (NASDAQ:SNDL)

Alberta, Canada-based Sundial Growers Inc. is another entry that is new the NASDAQ trade. The cannabis producer made headlines in October of 2019 (and saw a brief cost boost) whenever it announced the production of a fresh Palmetto model of recreational cannabis, first for sale in Saskatchewan and Manitoba.

Therapix Biosciences Ltd. (NASDAQ:TRPX)

Therapix Biosciences Ltd. is just a specialty clinical-stage company that is pharmaceutical from the growth of cannabinoid-based medications. Therapix’s current pipeline includes services and products targeted to treat Tourette problem and mild thc and cbd impairment that is cognitive.

Tilray Inc. (NASDAQ:TLRY)

Tilray Inc. was the initial marijuana-related business to have a preliminary general public providing (IPO) in america. The Nanaimo, Vancouver company that is island-based on medical cannabis products.

Village Farms Global (NASDAQ:VFF)

Village Farms Overseas is considered the most current cannabis stock to begin trading on the NASDAQ. The business’s shares became readily available for trade on February 21, 2019. The business possesses history that is decades-long greenhouse produce manufacturing and contains just recently shifted a number of its focus toward cannabis manufacturing.

Zynerba Pharmaceuticals Inc. (NASDAQ:ZYNE)

Zynerba Pharmaceuticals is targeted regarding the development of synthetic treatments that are cannabinoid transdermal (through your skin) distribution. Their pipeline currently includes two medications being developed for indications including epilepsy, osteoarthritis, fibromyalgia, peripheral neuropathic discomfort, and delicate X syndrome.